open access
The use of anticoagulants in morbidly obese patients
open access
Abstract
Due to its constantly growing incidence, obesity is an increasingly serious social and medical problem. Available data on the use of novel oral anticoagulants in morbidly obese and obese patients are very limited. However, we tried to summarize the available knowledge on the use of anticoagulants in this subpopulation of patients in everyday clinical practice. Studies on the clinical use of anticoagulants provide a poor basis for any adjustment of doses in obese patients as compared to patients with normal body weight. In our opinion, further studies are required in this particular population.
Abstract
Due to its constantly growing incidence, obesity is an increasingly serious social and medical problem. Available data on the use of novel oral anticoagulants in morbidly obese and obese patients are very limited. However, we tried to summarize the available knowledge on the use of anticoagulants in this subpopulation of patients in everyday clinical practice. Studies on the clinical use of anticoagulants provide a poor basis for any adjustment of doses in obese patients as compared to patients with normal body weight. In our opinion, further studies are required in this particular population.
Keywords
morbid obesity, obesity, bariatric surgery, anticoagulant drugs, factor Xa inhibitors, heparin
About this articleTitle
The use of anticoagulants in morbidly obese patients
Journal
Issue
Article type
Review Article
Pages
12-16
Published online
2015-08-26
Page views
7760
Article views/downloads
15842
DOI
10.5603/CJ.a2015.0054
Pubmed
Bibliographic record
Cardiol J 2016;23(1):12-16.
Keywords
morbid obesity
obesity
bariatric surgery
anticoagulant drugs
factor Xa inhibitors
heparin
Authors
Justyna Domienik-Karłowicz
Piotr Pruszczyk
